United Therapeutics Corporation (UTHR.O)
58.63USD
9 Feb 2010
$1.34 (+2.34%)
$57.29
$57.49
$59.19
$57.49
666,710
1,030,164
$61.97
$27.34
UTHR.O
About
Overall
| Beta: | 0.53 |
| Market Cap (Mil.): | $3,084.48 |
| Shares Outstanding (Mil.): | 53.84 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| UTHR.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 11.50 | 3.76 |
| EPS (TTM): | -283.07 | -- | -- |
| ROI: | -8.18 | 1.25 | 2.30 |
| ROE: | -10.81 | 2.09 | 2.82 |
UPDATE 2-US FDA warns 3 drugmakers on misleading promotions
* Videos, waiting room sign draw objections (Adds company comments, details from letters)
Female CEOs' pay fell more than men's: survey
NEW YORK (Reuters) - Female chief executives earned just 58 percent of what their male counterparts did in 2008, and their compensation packages were slashed three times as much as their male peers, according to a survey released on Monday.
REFILE-U.S. female CEOs' pay fell more than men's-survey
* Women tend to head smaller companies than men - survey
UPDATE 1-Mondobiotech eyes share issue every 2 months
ZURICH, Aug 31 (Reuters) - Mondobiotech , which listed on the Swiss stock exchange last week, aims to raise 5-10 million Swiss francs ($4.7-9.4 million) every two months by issuing new shares, its chief executive said.
Swiss Mondobiotech to list on Zurich exchange
ZURICH, Aug 26 (Reuters) - Drug discovery company Mondobiotech is listing on the Swiss stock exchange, and plans to issue new shares on a regular basis to ensure its future funding, it said on Wednesday.
UPDATE 2-United Therapeutics lung drug gets FDA nod, shares rise
* Shares rise as much as 13 pct (Adds analyst comments, updates share movement)
UPDATE 4-United Therapeutics gets FDA nod for oral PAH drug
* Says Adcirca pricing comparable to Cialis on mg-to-mg basis
HEADLINE STOCKS-U.S. stocks on the move on May 26
(Updates to afternoon trade, adds Procter & Gamble, GM)
HEADLINE STOCKS-U.S. stocks on the move on May 26
NEW YORK, May 26 (Reuters) - Some U.S. stocks on the move on Tuesday:
Competitors
| Price | Change | |
|---|---|---|
| GlaxoSmithKline plc (GSK.L) | £-- | -- |
| Gilead Sciences, Inc. (GILD.OQ) | $46.33 | +0.24 |
| Teva Pharmaceutical Industries Limited (TEVA.TA) | ₪21,350.00 | +140.00 |
| Schering-Plough Corporation (SGP.N) | -- | -- |
| Actelion Ltd (ATLN.VX) | CHF-- | -- |
| Pfizer Inc. (PFE.N) | $17.88 | +0.04 |
| Eli Lilly & Co. (LLY.N) | $35.20 | +0.42 |
| EPIX Pharmaceuticals, Inc. (EPIX.PK) | $0.01 | +0.00 |
| Bayer AG (BAYGn.DE) | €-- | -- |
| Bayer AG (BAYE.F) | -- | -- |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
